Form 4 for CRL Charles River Laboratories
Accepted 2025-08-08 00:00:00 ET · period of report 2025-08-07 · accession 0001127602-25-020282 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-08-08 | 2025-08-07 | CRL | LaPlume Joseph W | EVP, Corp Strategy, Develop | S - Sale | $150.04 | -400 | 24.9K | -2% | -$60.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-08-07 | S | D | 400 | $150.04 | 24,916 | D | — | — |